A recent study suggests that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Research printed in a major health publication demonstrates that while overweight individuals often shed a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing these treatments should be informed of the potential of quick rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of regain means a return to starting mass in about 18 months.
Weighing Therapies
The analysis, which reviewed dozens of studies involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
The team point out that individuals who shed pounds through diet and exercise typically have a slower creep back—around 100 grams monthly—once they finish.
Understanding the Rapid Regain
Experts propose the mechanism of the jabs accounts for the amplified regain.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Disease?
Health authorities advise the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts contend that, considering the significant potential of weight regain, the treatment might need to be ongoing.
This view is reinforced by pharmaceutical companies, who state that the results "highlight the long-term nature of obesity," comparing it to managing diseases like high blood pressure.
User Experiences
People who have discontinued the medication report a intense resurgence of cravings.
"I experienced a switch flipping and you're instantly ravenous," said an individual.
This difficulty is worsened if users have not adopted sustainable dietary or behavioural changes during treatment.
Growing Use
Survey data indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Use is greater among females than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone fix and long-term success likely depends on ongoing lifestyle support.
